Fr. 57.50

ANTI-CANCER ACTIVITY OF PARMELIA PERLATA ETHANOLIC EXTRACT - DE

English · Paperback / Softback

Shipping usually within 1 to 2 weeks (title will be printed to order)

Description

Read more

As the world's top cause of mortality, cancer is currently the most prevalent barrier to achieving a good life expectancy in most nations. Ovarian cancer is the third most frequent gynecologic cancer, after cervical and uterine cancer. It also has the worst prognosis and the highest death rate. Ovarian cancer is less common than breast cancer, yet it is three times as dangerous. It is projected that this sickness will cause a significant increase in deaths by 2040. The slow development of symptoms, hidden and silent growth of the tumour, and insufficient screening are all factors in the high fatality rate from ovarian cancer. This suffering is exacerbated by the present cancer screening methods' inadequate diagnostic effectiveness. In conventional medicine, chemotherapy comes after surgical debulking. Chemotherapy is a frequently used cancer treatment strategy. But the side effects of chemotherapy medications are quite awful and poisonous. This book deals with the ovarian cancer cell line (PA-1) used to test the anti-cancer effects of ethanolic extract of Parmelia perlata.

Product details

Authors A. Arulmozhi, A. Jayaprakash
Publisher LAP Lambert Academic Publishing
 
Languages English
Product format Paperback / Softback
Released 25.11.2024
 
EAN 9783330047112
ISBN 978-3-33-004711-2
No. of pages 52
Subject Natural sciences, medicine, IT, technology > Biology > Biochemistry, biophysics

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.